跳至主要内容
临床试验/NCT01419496
NCT01419496已完成不适用

Identifying Stat3-Dependent Chemotherapy Resistance Pathways in Relapsed AML

Children's Oncology Group0 个研究点目标入组 40 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
Reduction in chemotherapy sensitivity by relapsed samples compared to diagnostic samples

研究概览

简要总结

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about cancer and development of drug resistance in patients.

PURPOSE: This research trial is studying proteins that may promote chemotherapy resistance in samples from patients with acute myeloid leukemia.

详细描述

OBJECTIVES:

  • Investigate whether changes in prosurvival signaling occur by comparing activation of the signal transducer and activator of transcription-3 (Stat3) and Stat5 pathways in paired diagnostic and relapse samples.
  • Investigate changes in leukemia cell responses to extrinsic cues from the environment change, using a bone marrow stromal-cell co-culture model of chemotherapy resistance.

OUTLINE: Cryopreserved samples are analyzed for Stat3 and Stat5 expression by flow cytometry and in vitro chemotherapy sensitivity.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 30 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Reduction in chemotherapy sensitivity by relapsed samples compared to diagnostic samples

Changes in Stat3 and Stat5 in paired diagnostic and relapsed AML samples

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验